WallStreetZenWallStreetZen

NYSE: UTI
Universal Technical Institute Inc Stock Forecast, Predictions & Price Target

Analyst price target for UTI

Based on 4 analysts offering 12 month price targets for Universal Technical Institute Inc.
Min Forecast
$14.00-7.47%
Avg Forecast
$16.25+7.4%
Max Forecast
$18.00+18.97%

Should I buy or sell UTI stock?

Based on 4 analysts offering ratings for Universal Technical Institute Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their UTI stock forecasts and price targets.

UTI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-08
lockedlocked$00.00+00.00%2024-01-25
lockedlocked$00.00+00.00%2024-01-10
lockedlocked$00.00+00.00%2023-11-16

1 of 1

Forecast return on equity

Is UTI forecast to generate an efficient return?

Forecast return on assets

Is UTI forecast to generate an efficient return on assets?

UTI revenue forecast

What is UTI's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$718.2M+8.47%
Avg 2 year Forecast
$757.6M+14.42%
UTI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

UTI revenue growth forecast

How is UTI forecast to perform vs Education & Training Services companies and vs the US market?
Company
8.47%
Industry
16.89%
Market
36.63%
UTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UTI vs Education Stocks

TickerPricePrice TargetUp/downsideConsensus
UTI$15.13$16.25+7.40%Strong Buy
CHGG$8.86$8.70-1.81%Sell
DAO$4.09N/AN/A
PRDO$17.59$23.00+30.76%Buy
VTRU$13.56N/AN/A

Universal Technical Institute Stock Forecast FAQ

Is Universal Technical Institute Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: UTI) stock is to Strong Buy UTI stock.

Out of 4 analysts, 2 (50%) are recommending UTI as a Strong Buy, 2 (50%) are recommending UTI as a Buy, 0 (0%) are recommending UTI as a Hold, 0 (0%) are recommending UTI as a Sell, and 0 (0%) are recommending UTI as a Strong Sell.

If you're new to stock investing, here's how to buy Universal Technical Institute stock.

What is UTI's revenue growth forecast for 2024-2025?

(NYSE: UTI) Universal Technical Institute's forecast annual revenue growth rate of 8.47% is not forecast to beat the US Education & Training Services industry's average forecast revenue growth rate of 16.89%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 36.63%.

Universal Technical Institute's revenue in 2024 is $662,099,000.On average, 3 Wall Street analysts forecast UTI's revenue for 2024 to be $38,587,970,401, with the lowest UTI revenue forecast at $38,368,421,379, and the highest UTI revenue forecast at $38,966,458,728.

In 2025, UTI is forecast to generate $40,706,838,759 in revenue, with the lowest revenue forecast at $40,567,672,835 and the highest revenue forecast at $40,846,004,683.

What is UTI's forecast return on assets (ROA) for 2024-2025?

(NYSE: UTI) forecast ROA is N/A, which is lower than the forecast US Education & Training Services industry average of 7.56%.

What is UTI's Price Target?

According to 4 Wall Street analysts that have issued a 1 year UTI price target, the average UTI price target is $16.25, with the highest UTI stock price forecast at $18.00 and the lowest UTI stock price forecast at $14.00.

On average, Wall Street analysts predict that Universal Technical Institute's share price could reach $16.25 by Feb 8, 2025. The average Universal Technical Institute stock price prediction forecasts a potential upside of 7.4% from the current UTI share price of $15.13.

What is UTI's forecast return on equity (ROE) for 2024-2025?

(NYSE: UTI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.